@prefix this: <http://purl.org/np/RAD28Nl4h_mFH92bsHUrtqoU4C6DCYy_BRTvpimjVFgJo> .
@prefix sub: <http://purl.org/np/RAD28Nl4h_mFH92bsHUrtqoU4C6DCYy_BRTvpimjVFgJo#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix pav: <http://purl.org/pav/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix infores: <https://w3id.org/biolink/infores/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix umls: <http://identifiers.org/umls/> .
@prefix orcid: <https://orcid.org/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo;
    a np:Nanopublication .
}

sub:assertion {
  <http://identifiers.org/pubchem.compound/37542> a biolink:ChemicalEntity;
    rdfs:label "Ribavirin", "ribavirin";
    biolink:category biolink:ChemicalEntity .
  
  <http://identifiers.org/pubchem.compound/91824755> a biolink:ChemicalEntity;
    rdfs:label "Technivie";
    biolink:category biolink:ChemicalEntity .
  
  umls:C1299487 a biolink:OrganismTaxon;
    rdfs:label "patients";
    biolink:category biolink:OrganismTaxon .
  
  <http://purl.obolibrary.org/obo/MONDO_0005155> a biolink:DiseaseOrPhenotypicFeature;
    rdfs:label "cirrhosis";
    biolink:category biolink:DiseaseOrPhenotypicFeature .
  
  sub:_1 rdf:object <http://purl.obolibrary.org/obo/MONDO_0005155>;
    rdf:predicate biolink:treats;
    rdf:subject <http://identifiers.org/pubchem.compound/37542>;
    a biolink:Association;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category biolink:Association;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc5ddcf2-640c-4683-a60f-ca1c8b418873> .
  
  sub:_2 rdf:predicate biolink:treats;
    rdf:subject <http://identifiers.org/pubchem.compound/37542>;
    a biolink:Association;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category biolink:Association;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc5ddcf2-640c-4683-a60f-ca1c8b418873> .
  
  sub:_3 rdf:predicate biolink:treats;
    rdf:subject <http://identifiers.org/pubchem.compound/37542>;
    a biolink:Association;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category biolink:Association;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc5ddcf2-640c-4683-a60f-ca1c8b418873> .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2022-10-13T13:58:05.814670"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-3668-2627;
    prov:wasQuotedFrom """Ribavirin is indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents. The addition of ribavirin in Technivie therapy indicated for treating HCV genotype 1a and 4 infections is recommended in patients with or without cirrhosis. Typically added to improve SVR and reduce relapse rates 6.9% of patients.
""" .
  
  biolink: pav:version "2.3.0" .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB";
    npx:hasSignature "bsq42BahwRuq9PbwjgEDiyTc6Z8j3PrPbOOhg4e1qHNafWwbrv1LBW9do2S3K97LrxqmlqXe/I9B2aftPzDTjB50NRhnVkKhg5QQvMEiRj9ytYecodplqCvljFyLryHygsyblpm6hCDRu5Mav7/+vBS6B+jy6p0aO9CBvPDk2cB3EPff9blEijI9Irufk1ZTDYJuubyDRIrC5seuRg2bR3YpzXj63xN1uLOQOVwy4BvYH58XgFGcvlYbBisHNC1xE/CEUaV86gnTml0hQ1/Y4jfDx52Oqr3CaazdhS+a6TJJtE7tYvS+QqFliEvT3BlICnUIiYwoHkZ54f1t9qTjbA==";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2022-10-13T13:58:05.814670"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-3668-2627 .
}